Tamminen-Möbius T, Brunier E, Ebel K D, Lebowitz R, Olbing H, Seppänen U, Sixt R
J Urol. 1992 Nov;148(5 Pt 2):1662-6. doi: 10.1016/s0022-5347(17)36997-5.
A total of 401 children with severe vesicoureteral reflux (97 with grade III and 304 with grade IV) was entered into the European branch of the International Reflux Study in Children. Of these patients 37 with grade III and 43 with grade IV reflux were allocated to medical treatment as a sideline group because the reflux grade III or IV had improved to grade II or I, or it had disappeared during the preceding 2 to 6 months (median 4). Of the remaining 321 patients with persistent grade III or IV reflux 158 were randomly allocated to medical treatment of whom 3 switched to surgery. We report on 235 children treated medically (155 random medical and 80 sideline), of whom 88% had a complete 5-year followup with x-ray and/or isotope voiding cystourethrography at 6, 18, 30 and 54 months. Seven children dropped out of the study after a followup of 6 months or less, including 6 with persistent vesicoureteral reflux. Cessation of vesicoureteral reflux was observed significantly more often in children with unilateral (40 of 74, 54%) than with bilateral (18 of 154, 12%) reflux (p < 0.001). No significant difference between grades III and IV was noted. Vesicoureteral reflux ceased in 25 of 153 children (16%) from the random medical group and in 32 of 75 children (43%) in the sideline group. Of 194 children with vesicoureteral reflux detected for the first time at entry reflux resolved in 55 (28%). In only 2 of 34 children (6%) in whom vesicoureteral reflux was detected more than 1 year before entry did reflux resolve after 5 years. Among the children in whom vesicoureteral reflux either disappeared, diminished or remained unchanged the proportion with urinary tract infection recurrences was almost the same.
共有401例患有重度膀胱输尿管反流的儿童(97例为III级,304例为IV级)进入国际儿童反流研究欧洲分支。在这些患者中,37例III级和43例IV级反流患者被分配到药物治疗作为一个附带组,因为反流III级或IV级已改善至II级或I级,或者在之前的2至6个月(中位数4个月)内已消失。在其余321例持续III级或IV级反流的患者中,158例被随机分配到药物治疗,其中3例转为手术治疗。我们报告了235例接受药物治疗的儿童(155例随机药物治疗和80例附带治疗),其中88%在6、18、30和54个月时通过X线和/或同位素排尿膀胱尿道造影进行了完整的5年随访。7例儿童在随访6个月或更短时间后退出研究,其中6例患有持续性膀胱输尿管反流。单侧反流儿童(74例中的40例,54%)膀胱输尿管反流停止的观察频率明显高于双侧反流儿童(154例中的18例,12%)(p<0.001)。III级和IV级之间未发现显著差异。随机药物治疗组153例儿童中有25例(16%)膀胱输尿管反流停止,附带治疗组75例儿童中有32例(43%)膀胱输尿管反流停止。在入组时首次检测到膀胱输尿管反流的194例儿童中,55例(28%)反流消失。在入组前1年以上检测到膀胱输尿管反流的34例儿童中,只有2例(6%)在5年后反流消失。在膀胱输尿管反流消失、减轻或保持不变的儿童中,尿路感染复发的比例几乎相同。